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TRACE LEVEL DETECTION OF ANALYTES 
USING ARTIFICIAL OLFACTOMETRY 
CROSS-REFERENCES TO RELATED 
Similarly, other volatile substances can interfere with the 
readings of the VSC. 
A second device for the detection of breath and odors 
associated therewith is based on zinc-oxide thin film semi- 
APPLICATIONS s conductor technology and has recently been developed for 
measuring vsc (see, Shimura M et al., J Periodontol. 
67:396-402 (1994)). New Cosmos cO. (Osaka, 
Japan) manufactures this device. This device, however, is 
limited because it is susceptible to interference from organic 
i o  vapors unrelated to oral malodor (see, Yaegaki K, In 
Rosenberg, “Bad Breath: Research Perspectives,” Proceed- 
ings of the First International Workshop on Oral Malodor, 
Ramot Publishing, Tel Aviv University pp. 41-54 (1993)) 
87-108 (1995)). 
Another analysis for breath detection is a test based on the 
enzyme substrate benzoyl-DL-arginine-naphthylamine 
This application claims priority to U.S. Provisional Appli- 
cations Ser. No. 601090,012, filed Jun. 19,1998, and Ser. No. 
601091,179, filed Jun. 30,1998, the disclosures of which are 
incorporated herein by reference in their entirety. 
STATEMENT AS TO RIGHTS TO INVENTIONS 
MADE UNDER FEDERALLY SPONSORED 
RESEARCH AND DEVELOPMENT 
The research carried out in the subject application was 
sponsored, in part, by grants from: ARo (E)AAG-55-97-1- 15 
0187); DARPA (DM60-97-K-9503);  and NASA (49- 
244-30002-0-8280), and is subject to the provisions of (BANA) (see, et  J .  Microbiol.  
Public Law 96-517 (35 U,S,C, 5 202). The government may et al. Periodontol., 28:1551-1559 (1991); and 
61:189-196 (1991)). This test is marketed under the brand 
20 name Peroscan and is available from Oral-B Laboratories 
(Redwood City, Calif.). Scrapings from the tongue, saliva, or 
plaque samples are deposited directly on a reagent card. 
obes are present. Studies have shown that BANAresults are detecting a wide variety of analytes in fluids such as vapors, 
25 not highly correlated with VSC measurements and that the gases and liquids. The device comprises an array of sensors that in the presence of an analyte produces a response. The test is often detecting other analytes (see, Kozlovsky et al., 
J Dent. Res., 73: 103-1042 (1994)). device produces a unique signature output for a particular 
signature, such as an electrical response, can be correlated suffers from chronic oral malodor (see, Bosy, J.  Can. Dent. 
population is worried about bad breath, even though there is stances that are known. By comparing the unknown signa- 
usually no underlying disease (see, Iwakura et al, J.  Dent. ture with the stored or known signatures, the analyte can be 
Res. 7:1568-1574 1 (1994)). Food, of course, is another detected, identified and quantified. 
There are many instances where it is desirable to measure of oral malodors, H ~ ~ ~ ~ ~ ~ ,  there are many people 
trace amounts of analytes. However, in certain instances, the 35 who have an unwarranted phobia of bad breath, The size of 
robust signal by direct exposure to currently available sen- 
sors. In headspace analysis of applications in agricultural, In addition to mammalian breath measurements, respira- 
detection and classification of trace levels of gases are 40 be monitored at very low concentrations of analytes. Medi- 
detection difficult. Moreover, in residue analysis of pesti- delivery to the patient, an anesthetic device, it is impera- 
cides on crops, the trace levels of certain herbicides must tive that the concentration of the anesthetic, gas flow and 
meet federal guidelines. For certain crops, these residues are amounts of the mixture and starting gases be known with 
present On the crops in the part per 45 certainty. In most instances, the anesthetic amounts are at 
Another potential application wherein the detection of very low concentration levels, 
trace levels of analytes is important is the diagnosis of One approach to increase sensitivity to certain analytes is 
patients’ conditions from an analysis of their breath. Marker to use selective filters or membranes, For instance, U.S. Pat, 
gases such as hydrogen sulfide and methyl mercaptan, which No. 5,841,021, which issued to De Castro et al., discloses an 
are important in diagnosing the Presence of oral or lung SO electrochemical gas sensor that has a catalytically active 
conditions from the breath of human Patients, often exist in sensor electrode, a reference electrode and a permselective 
Concentrations of 0.01-1 Parts Per million (Or lower). filter or membrane layer. The filter is made of a material that 
However, the threshold detection levels of currently known provides for molecular specificity of certain gases, such as 
sensors are in the range of 1-100 parts per million. carbon monoxide. The membrane allows the sensors to be 
Currently, the most widely used device for detecting oral ss selective to the chemical analyte of interest. The filter only 
malodors is the Halimeter, which is commercially available allows the analytes of interest to contact the sensor. By 
from Interscan Corp. (Chatsworth, Calif.). Using an elec- removing interfering substances through filtration, the sen- 
trochemical cell that is sensitive to volatile sulfur com- sor becomes more selective and thus sensitive to the analyte 
pounds (VSC), the device can oxidize the VSC at the anode of interest. 
according to the following reactions: In addition, U.S. Pat. No. 5,057,436, which issued to Ball, 
discloses a method and apparatus for detection of toxic 
gases, such as ammonia, using a metal oxide semiconductor 
and an electrochemical sensor. Disposed between the two 
sensors is an absorber having an absorbent that reacts with 
In view of the foregoing, what is needed in the art is a 
vapor concentrator for an array of sensors, especially for an 
have certain rights in any patents issuing on this application. 
BACKGROUND OF THE INVENTION 
An system is a device that is capab1e Of Following substrate addition, a blue spot develops if anaer- 
analyte. Using pattern recognition the Output It has been estimated that at least 50% of the population 
and ‘Ompared to a particular analyte Or mixture Of sub- 30 Assoc, 63:196-201 (1997)). A significant fraction of the 
analytes are found at levels that are too low to register a the market for breath fresheners, chewing gums, and mouth 
rinses is an indicator of this propensity, 
wine, tobacco, perfume, plastics, and the food industries, the 
present in the sub part per (ppm) range, making 
tory devices for anesthetic and respiratory gas mixtures must 
cal devices mix the anesthetic with breathing gas prior to 
levels b b ) .  
60 
H2S-S+2Hf+2e- 
2CH3SH-CH3S-S4H3+S+2Hf+2e- 
CH3S4H3+2H20-2CH30H+S+2Hf+2e~ 
65 ammonia. 
However, one obvious drawback is that the Halimeter 
cannot distinguish between volatile sulfur compounds. 
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electronic nose sensor array. In addition, methods are needed 
to detect odors and diagnose medical conditions. The present 
invention fulfills these and other needs. 
SUMMARY OF THE INVENTION 
In certain instances, it is desirable to measure trace 
amounts of analytes using sensor array technology. The 
present invention increases the sensitivity to such analytes 
by a large factor, and thus allows for the use of existing 
sensor systems for applications where an increase in sensi- 
tivity renders them more effective. As such, in certain 
aspects, the present invention provides a device for detecting 
the presence of an analyte, the device comprising: a sample 
chamber having a fluid inlet port for the influx of the analyte; 
a fluid concentrator in flow communication with the sample 
chamber, wherein the fluid concentrator has an absorbent 
material capable of absorbing the analyte and capable of 
desorbing a concentrated analyte; and an array of sensors in 
fluid communication with the concentrated analyte. In cer- 
tain preferred embodiments, the device further includes a 
detector operatively associated with each sensor that pro- 
vides a response in the presence of the analyte. 
The absorbent material of the fluid concentrator can be, 
but is not limited to, a nanoporous material, a microporous 
material, a chemically reactive material, a nonporous mate- 
rial and combinations thereof In certain instances, the absor- 
bent material can concentrate the analyte by a factor that 
exceeds a factor of about lo5, and more preferably by a 
factor of about 10’ to about lo4. Using the device of the 
present invention, the analyte can be concentrated from an 
initial sample volume of about 10 liters and then desorbed 
into a concentrated volume of about 10 milliliters or less, 
before being presented to the sensor array. 
In another embodiment, removal of background water 
vapor is conducted in conjunction, such as concomitantly, 
with the concentration of the analyte. Once the analyte is 
concentrated, it can be desorbed using a variety of 
techniques, such as heating, purging, stripping, pressuring or 
a combination thereof 
In yet another aspect, the present invention provides 
methods for detecting or diagnosing, for example, 
infections, lung cancer, oral infections and halitosis using a 
breath sample of a mammal. Preferably, the mammal is a 
human being. In other embodiments, the present invention 
provides methods for other medical applications, such as 
those involving the detection of marker gas(es) in mamma- 
lian breath as well as odors from potentially infected areas 
of the skin. 
In still yet another aspect, the present invention provides 
methods and devices for the process control of anesthetic 
gases of clinical interest. Using the apparatus of the present 
invention, monitoring and quantitating anesthetics is readily 
accomplished. 
These and other embodiments and advantages will be 
readily apparent when read with the accompany drawings 
and the detailed description of the invention which follows. 
BRIEF DESCRIPTION OF THE DRAWINGS 
FIG. 1 is a cross-sectional view of a breath collector and 
FIG. 2 is a cross-sectional view of a breath collector and 
FIG. 3 is a head space analyzer of the present invention. 
FIG. 4 is a block diagram of a vaporizing system of the 
concentrator of the present invention. 
concentrator of the present invention. 
present invention. 
4 
FIGS. 5A and 5B illustrate various response patterns 
obtained using the devices of the present invention. Panel A 
illustrates the responses of 32 sensors to anerobius (Bacl), 
gingivalis (Bac2) and a control; Panel B illustrates responses 
s of 32 sensors to anerobius (Bacl), gingivalis (Bac2) and a 
control (Expanded y-axis). 
FIG. 6 illustrates the results of principle component 
analysis on a data set of Ps anerobius (Bacl) and P gingi- 
valis bacteria (Bac2) plus the control (the medium in which 
FIG. 7 illustrates the response of sensors in the presence 
FIG. 8 illustrates the results of the response of sensor 
10 the bacteria were grown). 
of 3 percent halothane. 
15 array in the presence of halothane. 
DETAILED DESCRIPTION OF THE 
INVENTION AND PREFERRED 
EMBODIMENTS 
20 I. The Device 
In one aspect, the present invention allows existing sensor 
systems to be more effective and efficient by providing 
enhancements in the detection sensitivity to trace analytes. 
As such, in one embodiment, the present invention provides 
a device for detecting the presence of an analyte in a fluid, 
comprising: 
a) a sample chamber having a fluid inlet port for the influx 
of the analyte; 
b) a fluid concentrator in flow communication with the 
sample chamber, the fluid concentrator having an 
absorbent material capable of absorbing the analyte and 
capable of desorbing a concentrated analyte; and 
c) an array of sensors in fluid communication with the 
In preferred embodiments, the device further comprising 
a detector operatively associated with each sensor that 
provides a response in the presence of an analyte. In certain 
embodiments, the sample chamber is designed for the col- 
40 lection of mammalian breath. Under certain conditions, 
mammalian breath contains marker gases indicative of cer- 
tain infections, disorders and medical conditions and the 
devices of the present invention can be used to detect such 
marker gases. In certain aspects, the sample chamber is a 
45 breath collector and concentrator (BCC) and is fabricated to 
collect the breath of a mammal. Preferably, the mammal is 
a human being, although the BCC can be fabricated to 
collect the breath of other mammals such as cows, sheep, 
horses, dogs, cats, hogs, etc. The BCC is convenient to use 
SO and in certain instances is a portable handheld device with 
a suitable handle portion for convenient use. 
With reference to FIG. 1, in certain embodiments, the 
sample chamber is a cylindrical reservoir having an inlet 
port (10) for the influx of gas, such as breath, and an outlet 
ss port (19) for the exhaust of breath. The BCC has a first end 
and a second end. The cylindrical container (12) extends 
between the first end and the second end, and the cylindrical 
container has an open interior chamber (13). 
The first end of the body is open for access to the interior 
60 chamber and functions as a breath inlet port and is vented by 
a breath exhaust. The breath inlet port optionally contains a 
disposable adapter for multiple use. A concentrator portal 
(14) opens into the interior chamber and is in flow commu- 
nication with the fluid concentrator. The fluid concentrator 
65 (15) comprises an absorbent material capable of absorbing 
the analyte and capable of desorbing a concentrated analyte. 
In certain embodiments, valves control the breath flow so the 
2s 
30 
35 concentrated analyte. 
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sample of breath within the chamber can be directed to the 
fluid concentrator. The fluid concentrator optionally contains 
a second exhaust or exit port. 
A valve (16) is mounted anterior to the outlet Port with 
sufficient force to maintain the vent closed except when the 5 
mammal is exhaling into the chamber. Optionally, the fluid 
desorbing a concentrated analyte. As illustrated in FIG. 1, 
interior chamber and is in fluid communication with the 
desorbed concentrated analyte and the sensor array (11). In 
ing includes a robotic armature system. In general, these 
systems include automated workstations like the automated 
apparatus developed by Takeda Chemical Industries, LTD. 
(Osaka, Japan) and many robotic systems utilizing robotic 
(Zymate 11, Zymark Corporation, Hopkinton, MA,; 
Orca, Hewlett-Packard, Palo Alto, Calif.), which mimic the 
and implementation of modifications to these devices (if 
i o  skilled in the relevant art. 
concentrator is jacketed (17) with a heater for the purpose Of manual operations performed by a technician. The nature 
the BCC has a array porta' (18) that 'pens into the any) so that they can operate will be apparent to persons 
certain embodiments, the array is disposed down- In 'peration, a Of the gas to be as 
stream of the inlet port and the concentrator portal, In other human breath, is introduced into a chamber where it 
embodiments, the array is disposed between the inlet is transported by means of convention into the vicinity of the 
port and the concentrator portal (not shown), certain sorbent material. Suitable transporting means include, but 
embodiments, the BCC has an adapter to provide breath 15 are not limited to, a fan, an air pump, or it can be means for 
from the nostril(s) to avoid cross-contamination from the heating the cylindrical container (12) to create a convective 
mouth. air flow between the inlet and the outlet. The sorbent 
In certain aspects, the BCC can be a desktop model. As material is chosen from known materials designed for the 
illustrated in FIG. 2, the first end (24) of the BCC (20) is purpose of sorbing gases, vapors, and the like. In certain 
open for access to the interior chamber (22) and functions as 20 embodiments, the sorbent material includes, but is not 
a breath inlet port and is vented by a breath exhaust (25). A limited to, a nanoporous material, a microporous material, a 
fluid concentrator (23) opens into the interior chamber (27) chemically reactive material, a nonporous material and 
and is in flow communication (28) with the breath exhaust combinations thereof Such absorbents include, for example, 
(25). In this embodiment, the breath is circulated through the activated carbon, silica gel, activated alumina, molecular 
chamber using a fan (21). The sensor array (26) is in flow zs sieve carbon, molecular sieve zeolites, silicalite, AIPO,, a 
communication with the desorbed analyte. 
In various embodiments, the fluid concentrator can be 
disposed within the sample chamber or outside the sample 
chamber. In addition, the sensor array can be disposed 
within the sample chamber or outside the sample chamber. 
Moreover, the sensor array can be configured to be external 
from the BCC and to extend into the mouth or nasal cavity. 
The present invention embodies all such variations. 
Although the device of FIG. 1 is shown as a handheld 
breath collector and concentrator. those of skill in the art will 
polymer, a co-polymer, alumina and mixtures thereof In 
certain embodiments, the absorbent has a pore size from 
about 1 nm to about 100 nm and, preferably, from about 1 
nm to about 50 nm. 
Suitable commercially available adsorbent materials are 
disclosed in U.S. patent application Ser. No. 091271873, 
filed Mar. 18, 1999, and include, but are not limited to, 
Tenax TA, Tenax GR, Carbotrap, Carbopack B and C, 
Carbotrap C, Carboxen, Carbosieve SIII, Porapak, 
35 Saherocarb. and combinations thereof. Preferred adsorbent 
30 
appreciate that in certain other embodiments, the device and combinations include, but are not limited to, Tenax GR and 
methods of the present invention can be adapted and con- Carbopack B; Carbopack B and Carbosieve SIII; and Car- 
figured to detect within or around various other areas of bopack C and Carbopack B and Carbosieve SI11 or Car- 
interest including, but not limited to, mucous membranes, boxen 1000. Those skilled in the art will know of other 
nose, nasal passages, eye, skin, ear, inner ear, mouth, tongue, 40 suitable absorbent materials. 
throat, colon, duodenum, body cavities, stomach, vagina and After sometime period that is chosen to be adequate for 
penis. Moreover, the device and methods of the present sorbing the desired analytes from the vapor phase onto the 
invention can be configured to detect all body fluids material, the circulation is stopped and then the material is 
including, but not limited to, urine, perspiration, tears, desorbed from the sorbent phase and released into the sensor 
blood, mucus, pus, salvia, feces, menstruation fluid, sperm, 45 chamber. The desorbing of the concentrated analyte for the 
eggs, spinal fluid and mammary gland discharge. sorbent can be by accomplished by thermal means, mechani- 
In another embodiment, the sample chamber is a head cal means or a combination thereof. Desorption methods 
space analyzer (HSA) and can be fabricated from an inert include, but are not limited to, heating, purging, stripping, 
material, such as a molded fiberglass, or in certain embodi- pressuring or a combination thereof 
ments can be fabricated from plastic and can be configured SO In certain embodiments, the sample concentrator is 
like a box. As illustrated in FIG. 3, the sample chamber (32) wrapped with a wire through which current can be applied 
optionally has a glass-viewing window and the box can to heat and thus, desorb the concentrated analyte. The 
contain pressure and temperature gauges (37) to allow analyte is thereafter transferred to the sensor array. 
pressure and temperature monitoring. Moreover, the sample The process of sorbing the material onto the sorbent phase 
chamber optionally contains valves for gas input and ss not only can be used to concentrate the material, but also can 
exhaust of the box. Optionally, the sample chamber com- be advantageously used to remove water vapor. The water 
prises a heater and a pressure control means for an internally vapor is preferably removed prior to concentrating the 
controlled atmosphere. analyte; however, in various embodiments, the vapor can be 
Similar to the BCC, the HSA has a first end (34) that is removed concomitantly or after the analyte is concentrated. 
open for access to the interior chamber (32) and functions as 60 In a preferred embodiment, the water vapor is removed prior 
an inlet port (30) and is vented by an exhaust (35). A fluid to presenting the desired analyte gas mixture to the sensor 
concentrator (33) is disposed outside the sample chamber array. Thus, in certain embodiments, the fluid concentrator 
and is in flow communication (36) with the exhaust (35). contains additional absorbent material to not only concen- 
The sensor array (39) is in flow communication with the trate the analyte, but to remove unwanted materials such gas 
desorbed analyte. 
Optionally, the HSA contains appropriate connections for In certain instances and depending on the absorbent used, 
high throughput screening (HTS). High throughput screen- the concentration factor can exceed a factor of lo5, and more 
65 contaminates and moisture. 
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preferably by a factor of about 10’ to about lo4 Thus, the sensing the presence of an analyte in a fluid with a chemical 
analyte gases can be concentrated from an initial sample sensor comprising first and second conductive leads electri- 
volume of about 10 liters and then desorbed into a volume cally coupled to and separated by a chemically sensitive 
of about 10 milliliters or less when they are presented to the sensor as described above by measuring a first response 
sensor array. 5 between the conductive leads when the sensor is contacted 
The array of sensors is present in fluid communication with a first fluid comprising an analyte at a first concentra- 
with the concentrated analyte. Various sensors suitable for tion and a second different response when the sensor is 
detection of analytes include, but are not limited to: surface contacted with a second fluid comprising the analyte at a 
acoustic wave (SAW) sensors; quartz microbalance sensors; second different concentration. As discussed above, suitable 
conductive composites; chemiresitors; metal oxide gas responses include, but are not limited to, resistance, 
sensors, such as tin oxide gas sensors; organic gas sensors; impedance, capacitance, inductance, magnetic, optical, etc. 
11. Medical Applications metal oxide field effect transistor (MOSFET); piezoelectric devices; infrared sensors; temperature sensors, humidity 
sensors, sintered metal oxide sensors; Pd-gate MOSFET; The methods and apparatus of the Present invention are 
metal FETstructures; metal oxide sensors, such as a Tuguchi extremely useful and can be advantageouslY used for the 
gas sensors; phthalocyanine sensors; e~ectrochemica~ cells; 15 detection, identification, and classification of trace gas 
conducting polymer sensors; catalytic gas sensors; organic components, and are extremely useful in a variety of 
semiconducting gas sensors; solid electrolyte gas sensors; applications, including medical applications. In certain 
piezoelectric quartz crystal sensors; dye-impregnated poly- aspects, the methods and devices of the present invention are 
mer films on fiber optic detectors; polymer-coated micro- useful and very effective for the detection and diagnosis of 
mirrors; electrochemical gas detectors; chemically sensitive 20 diseases. In general, certain volatile marker gas (es) char- 
field-effect transistors; carbon black-polymer composite acterizes the detection or diagnosis of a disease state or 
chemiresistors; micro-electro-mechanical system devices; medical condition. The methods and apparatus of the present 
and micro-opto-electro-mechanical system devices and invention can advantageously by used to detect volatile 
Langmuir-Blodgett film sensors. marker gases and compounds indicative of medical 
In a preferred embodiment, the sensors used in the present zs conditions, disease processes, infections, illness and well- 
invention are disclosed in U.S. Pat. No. 5,571,401, which is being. Using these marker gases and compounds, clinicians 
incorporated herein by reference. Briefly, the sensors can use the diagnostic instruments and methods of t he 
described therein are conducting materials and nonconduct- present invention to make diagnoses and formulate appro- 
ing materials arranged in a matrix of conducting and non- priate treatments. The methods as described can optionally 
conducting regions. The nonconductive material can be a 30 be performed using a fluid concentrator as described herein. 
nonconducting polymer such as polystyrene. The conductive A. Oral infections 
material can be a conducting polymer, carbon black, an In certain aspects, the present invention is extremely 
inorganic conductor and the like. The sensor arrays comprise useful for the detection of infections, such as oral infections 
at least two sensors, typically about 32 sensors, and in and dental cares. For example, bacteria cause two wide- 
certain instances 1000 or more sensors up to about lo6 35 spread dental problems-halitosis and periodontal disease- 
sensors. In a preferred embodiment, at least two sensors are and, as disclosed herein, the methods and apparatus of the 
compositionally different. The array of sensors can be present invention can detect the off-gases produced by such 
formed on an integrated circuit using semiconductor tech- bacteria. 
nology methods, an example of which is disclosed in PCT 1. Halitosis 
Patent Publication No. WO99108105, entitled “Techniques 40 Halitosis is caused by the breakdown of proteins by 
and Systems for Analyte Detection,” published Feb. 19, microbes on the back of the tongue. The tongue coating is 
1999, and incorporate herein by reference. Another preferred comprised of epithelial cells from the oral mucosa, leuko- 
sensor system is disclosed in PCT Patent Publication No. cytes from periodontal pockets, and microorganisms. While 
WO99127357, published Jun. 6, 1999. the mouth is resident to over 300 bacterial species (see, 
In certain embodiments, the temporal response of each 45 Loesche et al., In Rosenberg M., Editor, “Bad Breath: 
sensor (response as a function of time) is recorded and can Research Perspectives,” Proceedings of the First Znterna- 
be displayed. Various responses include, but are not limited tional Workshop on Oral Malodor, Ramot Publishing, Tel 
to, resistance, impedance, capacitance, inductance, Aviv University pp. 41-54 (1993)), the relative size of each 
magnetic, optical, etc. The temporal response of each sensor population is a function of many factors. Bad breath has 
can be normalized to a maximum percent increase and SO been associated with the expansion of anaerobic species 
percent decrease that produces a response pattern associated (see, Loesche et al., In Rosenberg Ed., “Bad Breath: 
with the exposure of the analyte. By iterative profiling of Research Perspectives,” Proceedings of the First Znterna- 
known analytes, a structure-function database correlating tional Workshop on Oral Malodor, Ramot Publishing, Tel 
analytes and response profiles is generated. Unknown ana- Aviv University pp. 41-54 (1993); de Boveri HE et al., J .  
lytes can then be characterized or identified using response ss Am. Dent. Assoc., 126:1384-1393 (1995)). The underlying 
pattern comparison and recognition algorithms. cause of the increase in anaerobes can be poor oral hygiene, 
Accordingly, analyte detection systems comprising sensor aging, deep crevices in the tongue, post-nasal drip, or 
arrays, a measuring device for detecting responses across numerous other conditions. 
each sensor, a computer, a display, a data structure of sensor The chemical markers of bad breath have been identified 
array response profiles, and a comparison algorithm(s) or 60 and include, but are not limited to, volatile sulfur com- 
comparison tables are provided. In another embodiment, the pounds (VSC) (see, Richter et al., Arch. Oral Biol., 9:47-53 
electrical measuring device or detector is an integrated (1964); Tonzetics Arch. Oral Biol., 16:587-597 (1971); 
circuit comprising neural network-based hardware and a Tonzetich, J .  Periodontol. 48: 13-20 (1977); Tonztich J, J .  
digital-analog converter (DAC) multiplexed to each sensor, Znt. Dent. J .  28:309-319 (1978); and Tonzetich, Arch. Oral 
or a plurality of DACs, each connected to different sensor(s). 65 Biol., 16:587-597 (1971)). 
In certain embodiments, a method for using the sensors As such, the present invention provides a method for the 
for detecting the presence of an analyte in a fluid involves detection of halitosis, the method comprising: contacting an 
10 . 
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array of sensors with mammalian breath suspected of con- 
taining a marker gas indicative of halitosis; and detecting the 
marker gas to determine the presence of halitosis. In pre- 
ferred embodiments, the marker gases being detected by the 
sensors are volatile sulfur compounds. 
C. Wound Healing One of the major reasons for slow healing 
wounds can be a high level of bacteria. Frequently, wound 
healing is largely undetected due to lack of tests for detect- 
ing microorganisms. Slow wound healing is a problem that 
s effects more than a million people each year and costs 
billions of dollars to treat. Unfortunately, one of the standard 
periodontal disease. Gingivitis is the inflammation of the the dressing, Nurses are advised to be aware of a  repulsive^^ 
gums and periodontitis is when the gum infection damages odor that may be associated with necrotic tissue and “acrid 
i o  or putrid” smells that are associated with anaerobic bacteria. the bone and supporting tissues. These conditions are the result of the expansion of certain species of bacteria. If a 
piece of food is trapped between the teeth, the bacterial types these methods suffer from lack Of specificity’ 
that can utilize the various nutrients present will multiply, In While the absence of odor is indicative of a clean wound, the 
addition, of their metabolic products can give rise to presence of odor does not necessarily signal an infection The 
a second array of organisms, h d  finally, if the popu~ation switch in recent years to moisture-retaining “wet dressings” 
exp~osion of bacteria is to elicit an inflammatory is has further complicated the problem of wound assessment. 
response, a third wave of bacteria can arise that prefers the Most dressings have strong odors, but often times the odor 
gingival crevicular fluid (see, Loesche w J et al,, In is due entirely to the materials in the dressings. 
Rosenberg, Bad Breath Research Perspectives, Ramet While there is a quantitative culture methodology that can 
Publishing, Tel Aviv, pp. 41-54 (1993)). be employed to eliminate human errors, it is very expensive 
VSC are also an indicator of periodontal disease (see, 20 and time consumingh such, it is only used routinely in burn 
Loesche et al., In Rosenberg, BadBreath: Research centers where patients are in much more serious conditions. 
Perspectives, Ramat Publishing, Tel Aviv, (1995); Yaegaki et Advantageously, the present invention provides a method 
al., J .  Periodontia. Res. 27:233-238 (1992); Tonzetich et al., for diagnosing wound healing comprising: contacting the 
J .  Dent. Res 58:175 (1979); Frostell et al., Dent. J .  vapors associated with the wound with an array of sensors, 
20:436-450 (1970); Sat0 et al., Bull. Tokyo Dent. Coll., zs thereby assessing the wound healing process. 
21:171-178 (1980); Kostelc et al, J .  PeriodontalRes. D. Vaginitis 
15:185-192 (1980)). In addition, a number of other com- The vaginal discharge of women with bacterial vaginitis 
pounds can be indicative of various bacterial populations often has a prominent fishy odor. The presence of 
(see, Bosy et al.,J. Periodontal. 65:3746 (1994); McCulloch methylamine, isobutylamine, putrescine, cadaverine, 
et al., In Rosenberg, Bad Breath Research Perspectives, 30 histamine, tyramine, and phenethylamine are marker gases 
Ramat Publishing, Tel Aviv, pp. 109-117 (1995)). of vaginitis (see, Brand et al., Obstetrics and Gynecology, 
Asignificant development in recent years has been the use 68,682-685 (1985)). Thus, the present invention provides a 
of anti-microbials to treat periodontitis instead of surgery. It method for the detection of vaginitis, the method compris- 
has been shown that 80% of patients scheduled for surgery ing: contacting an array of sensors with vaginal vapors or 
or extractions could be successfully treated with a course of 3s discharge suspected of containing a marker gas indicative of 
metronidazole, doxycycline, or chlorhecidine. Overall, only vaginitis; and detecting the marker gas to determine the 
about 10% of the teeth required the conventional surgery or presence of vaginitis. 
extraction. Surprisingly, by using the apparatus of the E. Fertility 
present invention, it is possible to make a quick diagnosis, In yet another aspect, the present invention provides 
thereby alleviating unnecessary surgery. 40 methods and apparatus for the detection of ovulation. The 
As such, the methods and apparatus of the present inven- fertile period of a female mammal, such as a human being, 
tion can be used for the detection of periodontal disease. can be detected by measuring axillary secretions. The mark- 
Thus, the present invention provides a method for the ers are androstenol and/or dehydroepiandrosterone sulfate. 
detection of periodontal disease, the method comprising: Thus, the present invention provides a method for detecting 
contacting an array of sensors with mammalian breath 4s ovulation, the method comprising: contacting an array of 
suspected of containing a marker gas indicative of periodon- sensors with vaginal vapor for the presence of a marker gas 
tal disease; and detecting the marker gas to determine the indicative of ovulation; and detecting the marker gas to 
presence of periodontal disease. As explained above, and determine ovulation. 
detailed hereinbelow, numerous marker gases can be used to F. OTHER APPLICATIONS 
detect and evaluate the severity of periodontal disease. In addition to the foregoing applications, other applica- 
B. Pneumonia Detection tions for the methods and devices of the present invention 
In certain instances, it currently takes two to three days to include, but are not limited to, environmental toxicology, 
culture the bacteria and determine whether the species that remediation, biomedicine, material quality control, food 
cause pneumonia are present. Often, rather than waiting for monitoring, agricultural monitoring, heavy industrial 
this determination, medical personnel prescribe broad- ss manufacturing, ambient air monitoring, worker protection, 
spectrum antibiotics. Unfortunately, this prophylactic pro- emissions control, product quality testing, oiligas petro- 
cedure can promote the emergence of antibiotic-resistant chemical applications, combustible gas detection, H,S 
strains . monitoring, hazardous leak detection, emergency response 
The methods and devices of the present invention can and law enforcement applications, explosives detection, 
alleviate the unnecessary prescribing of antibiotic(s) by 60 utility and power applications, foodlbeverageiagriculture 
providing rapid accurate detection and diagnosis of bacteria applications, freshness detection, fruit ripening control, fer- 
attributable to pneumonia. Thus, the present invention pro- mentation process monitoring and control, flavor composi- 
vides a method for the detection of pneumonia, the method tion and identification, product quality and identification, 
comprising: contacting an array of sensors with mammalian refrigerant and fumigant detection, cosmeticiperfume 
breath suspected of containing a marker gases indicative of 65 applications, fragrance formulation, chemicaliplasticsi 
pneumonia; and detecting the marker gas to determine the pharmaceut icals  appl icat ions,  fugi t ive emission 
presence of pneumonia. identification, solvent recovery effectiveness, hospital/ 
2. Periodontal Disease 
A far more serious consequence of oral infections is techniques of wound assessment is to smell the exudate on 
SO 
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medical applications, anesthesia and sterilization gas 
detection, infectious disease detection, breath analysis and 
body fluids analysis. 
Various other medical conditions and associated patho- 
gens are set forth in Table 1 
TABLE 1 
Infection 
INFECTIONS AND PATHOGENS 
Pathogen 
Area of 
Interest 
Acute sinusitis 
Pharyngitis 
Pneumonia 
Bronchitis 
American Thoracic 
Society (ATS) Class 111 
Severe CAP 
ATS Class IV-ICU 
CAP 
Cystitis in females; 
Pyelonephritis; Prostatitis or 
Epididymoorchitis 
Acute Meningitis 
Meningitis(post surgical); 
Brain abscess 
Biliary tract; Peritonitis or 
Diverticular abscess 
Cellulitis; Lymphangitis 
Cat bite, Dog bite, Decubitus 
ulcers,(uncomplicated) or 
Diabetic foot ulcer 
(uncomplicated); Toxic Shock 
EndometritisIEndomyometritis 
Pelvic Inflammatory Disease; 
Septic Thrombophlebitis 
(postpartum) 
Endocarditis (IE) 
Prosthetic valve 
Septic arthritis, Prosthetic 
joint, Osteomyelitis 
Strep. pneumoniae, H. flu, Sinus 
Moraxella catarrhais, Group 
A strep., G(+) anaerobes, 
Staph. aureus 
Group A, C, G strep. 
Strep. pneumoniae, Lungs 
Mycoplasma, Chlamydia 
pneumoniae, H. flu 
Strep. pneumoniae, H. Flu, Lungs 
Moraxella 
Strep. pneumoniae, H. Lung 
infuenzae, Klebsiella, Staph. 
aureus, Legionella Sp., 
Pseudomonas aerug., 
other gram-negative bacteria; 
Strep. pneumoniae, Staph. 
aureus, Legionella Sp., 
Pseudomonas aerug., other 
gram negative bacteria 
Enterobacteriaceae; Urinary 
Enterobacteriaceae & Tract 
Enterococcus sp. 
Hemophilus infuenzae, CNS 
Pneumococci, N. meningitidis 
Staphylococcus sp., gram- 
negative bacteria; 
Streptococcus sp., anaerobes, 
Staph. sp 
Enterobacteriaceae, Abdomen 
Enterococcus sp., anaerobes 
Streptococcus sp., Skin 
Staphylococcus sp.; Pasturella 
multicida, Staph & Strep., 
anaerobes; Gram negative 
bacteria; Gram-positive 
bacteria; Anaerobes 
Enterobacteriaceae, Pelvis 
Chlamydia sp., Streptococcus 
sp. (group B Streptococcus), 
Neiserria gonorrhoeae 
Streptococci sp. Heart 
Staphylococcus sp. 
Staphylococcus epi. 
Staphylococcus sp. & Strep. 
sp., Neisseria gonorrhoeae, Joint 
Staphylococcus sp., 
Staphylococcus sp., Staph & 
Strep. sp., Enterobacteriaceae, 
anaerobes 
Pharynx 
Bone & 
G. Markers 
As explained above, volatile sulfur compounds (e.g., H,S, 
C H , S H ,  CH,S-CH,) are the marker gases implicated 
in galitosis and periodontal diseases (see, Tonzetich, Arch. 
Oral Biol., 16:587-597 (1971); Rizzo, Periodontics, 
5:23314 236 (1967)). Other analytes that have been shown 
to correlate with such clinical findings include, but are not 
limited to, volatile organic acids (VOA), indolelskatole 
(indole), and diamines (see, Goldberg et al., J .  Dent. Res., 
73:1168-1172 (1994); Goldberg et al., In Rosesberg M Bad 
Breath Research Perspectives, Ramat Publishing, Tel Aviv, 
pp. 71-85 (1995)). 
In addition, several other analytes have been reported to 
be associated with oral infections including pyridines1 
picolines (see, Kostelc et al., J.  Periodont. Res., 15:185-192 
S 
10 
1s 
20 
2s 
30 
3s 
40 
4s 
so 
5s 
60 
65 
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(1981); Kostelc et al., Clin. Chem., 27342-845 (1981)). 
Overall, more than 80 volatile compounds have been shown 
to be associated with saliva or tongue scrapings (see, Claus 
et al., J.  High Resol. Chromatogr., 20:94-98 (1997)) and the 
methods and apparatus of the present invention can be used 
to advantageously detect such marker compounds and gases. 
Using the methods and apparatus of the present invention 
it is also possible to detect the off-gasses associated with 
bacteria associated with oral maladies including, but not 
limited to, Prevotella intermedia; Fusobacterium nuclea- 
tum; Porphyromonas gingivalis; Porphyromonas endodon- 
talis; Prevotella loescheii; Hemophilus parainfuenzae; Sto- 
matococcus muci; Treponema denticola; Veillonella 
species; Peptostreptococcus anaerobius; Micros prevotii; 
Eubacterium limosum; Centipeda periodontii; Selemonad 
aremidis; Eubacterium species; Bacteriodes species; Fuso- 
bacterium periodonticum; Prevotella melaninogenica; 
Klebsiella pneumoniae; Enterobacter cloacae; Citrobacter 
secies and Stomatococcus mucilaginus. 
Moreover, a wide variety of analytes and fluids can be 
detected and analyzed using the disclosed sensors arrays and 
electronic noses so long as the subject analyte(s) and fluids 
are capable of generating a differential response across a 
plurality of sensors of the array. Analyte applications include 
broad ranges of chemical classes including, but not limited 
to, organics such as alkanes, alkenes, alkynes, dienes, ali- 
cyclic hydrocarbons, arenes, alcohols, ethers, ketones, 
aldehydes, carbonyls, carbanions, polynuclear aromatics 
and derivatives of such organics, e.g., halide derivatives, 
etc.; biomolecules such as sugars, isoprenes and isoprenoids; 
VOC; VOA; indoles; skatoles; diamines; pyridines; 
picolines; fatty acids; and derivatives of the forgoing, etc. 
In addition to breath, the sensor arrays of the present 
invention can be used to identify various analytes in other 
biological fluids. These fluids include, but are not limited to, 
urine, perspiration, tears, blood, mucus, pus, salvia, feces, 
menstruation fluid, sperm, eggs, spinal fluid and mammary 
gland discharge. 
In general, most conditions and diseases listed herein 
have microorganisms associated with them. The presence of 
marker gases and compounds associated with the microor- 
ganism is in turn, indicative of the presence of the disease or 
condition. In a preferred embodiment, the off-gas of the 
microorganism is the marker that is detected by methods and 
devices of the present invention. 
111. ANESTHETICS 
In certain anesthetic vaporizers, a carrier gas, such as air, 
oxygen or nitrous oxide, is divided between a first stream 
directed to a chamber, wherein an anesthetic liquid is 
resident and a second stream or bypass stream. The first and 
second streams are recombined before delivery to the 
patient. Another version of an anesthetic vaporizer is 
embodied in a device wherein the anesthetic agent is 
injected directly into the carrier gas stream. 
In either instance, it is imperative that the concentration of 
volatile anesthetic liquid be known. The present invention 
provides methods and an apparatus for the process control of 
anesthetic gases. Using the methods and apparatus of the 
present invention, a fluid concentrator is optionally used 
when monitoring and quantitating anesthetic concentration. 
By using the apparatus and sensors described herein, it is 
possible to detect and quantitate the concentration of volatile 
anesthetics including, but not limited to, halothane, 
isoflurane, servoflurane, desflurane and enflurane. As such, 
the present invention provides an anesthetic vaporizing 
system for quantitating the concentration of the anesthetic, 
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comprising: a carrier gas source for delivering a carrier gas 
stream to a bypass valve, wherein the bypass valve splits the 
carrier gas stream into a first carrier gas stream for delivery 
to an inlet port and a second carrier gas stream for delivery 
to a joining valve; 
Ten samples of eleven bacteria, a fungus and ten controls 
were tested with the same sensor array used described 
above. Table 3 lists the bacteria plus the main metabolite 
known to be produced by these bacteria. Various statistical 
5 and mathematical techniques were used to analyze the data 
a vaporizing chamber for an anesthetic agent, comprising obtained with chemiresistors on these microorganisms. One 
the inlet port, an outlet port, a vaporizing and a of the methods used to classify the metabolites produced 
conduit for delivery of vaporized anesthetic from the from the various bacteria was principal component analysis, 
an unsupervised pattern recognition technique. PCA trans- outlet port to the joining valve; and 
forms multidimensional data sets into a lower dimensional an array of sensors in flow communication with the graphical representation, which describes a majority of the joining valve to quantitate the anesthetic. In preferred variation in a data set. PCAdefines a new set of axes to plot embodiments, the system further comprising a detector the samples, they are constructed so that a maximum amount operatively associated with each sensor that provides a of variation is described with a minimum number of axes, response in the presence of an anesthetic vapor. 
1~ and the data is hence readily visualized in this transformed With reference to FIG. 4, the carrier gas source (41) data space (see, K. R. Beebe, R. J. Pell, M. B. Seasholtz, delivers the carrier gas to a bypass valve (44), wherein the Chemometvics: A Practical Guide, Wiley, New York, 1998.) carrier gas is split between a first carrier gas stream for 
delivery to the inlet port (45) of the anesthetic vaporizer (40) the data set was Fisher 
and a second carrier gas stream which connects to a joining Linear Discrimination (FLD). FLD seeks a linear combina- 
valve (46), The anesthetic vaporizer contains a vaporizing 20 tion of the variables, which maximizes the ratio of its 
Another to 
means, such as a heater, pressure S O U C ~  or aspirator (48). The 
vaporizer includes an outlet port (42) for delivery of the 
between-group variance to its within-group variance (see, B. 
D. Ripley, Recognition and NemOvks, Uni- 
vaporized anesthetic through a conduit (43) to the joining 
valve, The array (49) is in flow commun~cat~on with Other algorithms used to analyze the data were K-nearest 
the joining valve. zs neighbor (KNN) and statistical isolinear multicategory 
tating an anesthetic vapor, comprising: containing the anes- pattern recognition methods used for predicting the class of 
detecting the response with a detector, thereby quantitating known membership. With KNN, a is 
30 always made, whether or not the unknown is a member of the anesthetic vapor. 
limit the present invention. algorithm than SIMCA because unlike SIMCA it makes no 
assumptions about the size or shape of the class. SIMCAcan 
detect if an unknown sample is not a member of any class 
3s in the training set. SIMCAuses the shape and position of the 
object formed by the samples in a class for class definition 
(see, K, R, Beebe, R, J, pell, M, B, Seasholtz, Chemomet- 
vics:A Practical Guide, Wiley, New York, 1998). The results 
obtained using all the described algorithms are set forth 
versity 19962 Chapter 32 p 93.). 
The present invention also provides a method of quanti- 
thetic vapor with a Sensor array to produce a response; 
analysis, SIMCA. Both of these algorithms are supervised 
unknown with given a training set Of 
The following examples are meant to illustrate and not the in the training set. KNN is a much simp1er 
IV. EXAMPLES 
Example 1 
In this Example, the detection and identification of bac- 
teria was conducted by measuring the metabolic Products 
produced from plate bacteria cultures carried out using an 
electronic nose (a 32-sensor array) and a Fisher Linear 40 below, 
Discrimination (FLD) algorithm. A. EXPERIMENTAL 
As shown herein, the data was also examined using 1. Testing Protocol 
principal component analysis (PCA) and statistical isohear  Thirty polymers were chosen based both on structural 
multicategory analysis (SIMCA). The results carried out on differences and on solubility to generate a thirty two sensor 
two very distinct bacteria, i.e.,peptostveplococcus anevobius 4s array. The testing protocol used for all the bacteria was the 
and povphyvomonas gingivalis, show that the two bacteria same and is described below. Anevobius and gingivalis were 
were clearly discriminated by the sensors as shown by PCA. tested in one day, whereas the rest of the bacteria were tested 
The metabolites of additional an 11 bacteria and one fungus over several days. 
plus controls were tested and the data was examined using Testing instrument: A Keithley electrometer and scanner 
PCA, SIMCA and FLD and discrimination among the bac- so were used to scan the resistances of 32 sensors during the 
teria was demonstrated. experiment. 
The objective of these experiments was to evaluate the Sampling: the headspace above the bacteria was sampled 
discriminating capability of a thirty-two sensor array com- using nitrogen gas as the carrier. The flow rate used was 100 
posed of mixtures of polymers and carbon black for metabo- mL/minute. No dilution with air was done. The flow rate of 
lites produced by a variety of bacteria. Fourteen fresh ss the background air used to purge the sensors was 10 
cultures were tested for the 20 most commonly suspected Liminute. No preconcentration was preformed. 
malodor producing, oral and pharyngeal anaerobic and fac- Temperature: The temperature of the substrates was not 
ultative bacteria including a fungus using a 32-sensor array. controlled and the measurements were done at room tem- 
The experiment was done in two phases. The first phase perature for the first phase study. The temperature of the 
consisted of testing two very distinct bacteria, peptostvep- 60 substrates was maintained at 28+0.1" C. for the second 
tococcus anevobius and povphyvomonas gingivalis, plus a phase study. 
control (the media in which the bacteria were independently Purge and Exposure times: For each sample test, there 
grown). Four sample tubes of each bacterium and the control were 60 seconds of background recording (purged with air), 
were tested to investigate reproducibility. The results from 120 seconds of exposure time, 120 seconds of recovery time 
the first test indicated that gingivalis and anerobius could be 65 (purged with air with RH level of about 3%), 180 seconds of 
discriminated from each other and the control using a sensor recovery without recording the data (purged with air), and 
array discussed herein. 30 seconds of final recording time (purged with air). 
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B. RESULTS AND DISCUSSION 
1. Sensor Array Response 
The response pattern of the 32-sensor array described 
above to anerobius, gingivalis, and the control is shown in 
FIG. 5 .  Note that the reproducibility of the sensor array was 
very good. The response (the normalized resistance change, 
(Rmm-R,)/R,), where R,, and R, are the maximum and 
base (initial) resistance, respectively) of the sensor array to 
each sample tested is employed to form a covariance matrix, 
which is used to do principal component analysis. PCA of 
the two bacteria plus control (data not shown) were clearly 
discriminated by the sensor array. SIMCA was also used to 
evaluate the data. The model was built with all the data as 
the training set and the data from the first test was used as 
the unknown. A classification rate of 100% was obtained 
using the SIMCA algorithm. KNN was also used to examine 
the data set. A model was built using the data from three 
sample tubes of each bacteria plus the control. One of the 
samples was used as the unknown. Using 3 or 5 nearest 
neighbors in the KNN algorithm gave a classification rate of 
66%. The FID algorithm was not used on this data set. 
In the second phase study, ten samples of 11 bacteria and 
one fungus were tested. The temperature of the substrates 
was controlled at 28+0.1" C. for all tests. The sample tubes 
were not temperatures controlled. As described in the experi- 
mental section, each bacterium was tested 19 times among 
9 test tubes. Thirty-two sensors responded to 11 bacteria and 
one fungus, 19 times for each. A covariance matrix that 
contained 32 columns (one column for each sensor 
response) and 12x19 rows (bacteria tested at different times) 
was formed. This matrix was used to do principal compo- 
nent analysis. 
16 
A different algorithm, Fisher Linear Discrimination, was 
introduced to process the data set. To construct a model 
using the FLD method, it is required that the data take the 
form of a square matrix. The columns and rows in the matrix 
correspond to the number of sensors and the number of test 
samples, respectively. Hence, to use FLD, the number of 
sensors needs to be equal to the number of sample tests. 
Each of the 11 bacteria and one fungus were tested 19 times 
thus, only 19 sensors could be used to construct the FLD 
model. Hence, a square matrix was formed using each of the 
bacteria tested 19 times and choosing 19 sensors out of the 
32. The very first test (tube 1) and the last test (tube 5) of 
each bacterium were used as unknowns. The first 19 sensors 
out of the 32-sensor array were found to give the highest 
prediction rate out of other sensor combinations. Twenty- 
four unknowns were predicted from the FLD model. The 
results provided a classification rate of 91.7% (see, Gibson, 
T. D., Prosser, O., Hulbert, J. N., Marshall, R. W., Corcoran, 
P., Lowery, P., Ruck-Keene, E. A,, Heron, S., Sensors and 
Actuators (B) 44, 413422,  1997). 
As a comparison, a SIMCAmodel was built with the same 
training set used for the FLD analysis. The same 24 
unknowns was used for SIMCA prediction. The results 
provided a classification rate of 75%. The KKN algorithm 
was also used and the classification rate was 66%. 
TABLE 2 
SENSOR COMPOSITION AND DEPOSITION CONDITIONS 
CHIP EM-1-070798 
P'er # Polymer 
Sensor Dilution 
# Solvent Ratio 
19 
22 
34 
3 s  
36 
5s 
73 
74 
3 
10 
12 
39 
42 
41 
48 
so 
54 
59 
63 
68 
80 
87 
9 s  
79 
63 
79 
86 
82 
90 
104 
10s 
102 
Hydroxypropyl cellulose 
Methyl vinyl ether-co-maleic acid, SO/SO 
Polyacrylamide 
Polyacrylamide, carboxyl modified (LC) 
Polyacrylamide, carboxyl modified (HC) 
Poly(ethy1ene oxide) 
Poly(viny1 alcohol), 100% hydrolyzed 
Poly(viny1 alcohol), 98% hydrolyzed 
CHIP EM-2-070798 
Alginic acid, sodium salt 
Ethylene-co-ethyl acrylate, 82/18 
Ethylene-co-vinyl acetate, 86/14 
1,2-Polybutadiene 
Polycaprolactone 
Poly(n-butyl methacrylate) 
Poly(n-ethyl methacrylate) 
Polyethylene, chlorinated (42 & Cl) 
CHIP EM-3-070798 
Polyethylene, chlorosulfonated 
Poly(isobuty1 methacrylate) 
Poly(a-methyl styrene) 
Polystyrene 
Poly(viny1 stearate) 
Styreneiethylenebutylene, ABA block 
Vinyl chlorideivinyl acetateihydroxypropyl 
Poly(viny1 pyrrolidone) 
CHIP EM-4-070798 
Poly(a-methyl styrene) 
Poly(viny1 pyrrolidone) 
Styrene-co-butyl methacrylate 
Styrene-co-acrylonitryle, 75/25 
Vinyl alcohol-co-vinyl butyral; 20180 
Poly(4-methoxy styrene) 
Poly methyl hydrosiloxane 
Poly diphenoxyphosphazene 
Sr 1 
Sr 2 
Sr 3 
Sr 4 
Sr 5 
Sr 6 
Sr 7 
Sr 8 
Sr 9 
Sr 10 
Sr 11 
Sr 12 
Sr 13  
Sr 14 
Sr 15 
Sr 16 
Sr 17  
Sr 18 
Sr 19 
Sr 20 
Sr 21 
Sr 22 
Sr 23 
Sr 24 
Sr 25 
Sr 26 
Sr 27 
Sr 28 
Sr 29 
Sr 30 
Sr 31 
Sr 32 
water 
water 
water 
water 
water 
water 
water 
water 
toluene 
toluene 
toluene 
toluene 
toluene 
toluene 
toluene 
toluene 
toluene 
toluene 
toluene 
toluene 
toluene 
toluene 
toluene 
water 
toluene 
water 
toluene 
THF 
THF 
THF 
THF 
THF 
150 to 1 
151 to 1 
150 to 1 
150 to 1 
150 to 1 
150 to 1 
150 to 1 
150 to 1 
2s  to 1 
2s  to 1 
2s  to 1 
2s  to 1 
2s  to 1 
2s  to 1 
2s  to 1 
2s  to 1 
2s  to 1 
2s  to 1 
2s  to 1 
2s  to 1 
2s  to 1 
2s  to 1 
2s  to 1 
150 to 1 
2s  to 1 
150 to 1 
2s  to 1 
100 to 1 
100 to 1 
100 to 1 
100 to 1 
100 to 1 
carbon black was used in each sensor at a concentration between 20-25 wt % 
17 
US 6,319,724 B3 
18 
TABLE 3 
LIST OF BACTERIA AND THEIR METABOLIC PRODUCTS 
BACTERIA NOMENCLATURE METABOLIC PRODUCTS OR OFF-GASES 
Enterobacter cloacae 
Cit. Koseri 
Psuedomonas Aeruginosa 
Veilonella species 
Prevotella melaninogenica 
Escherichia coli 
Klebseilla Pneumoniae 
Streptococcus mutans 
*Candida albicans 
Prevotella intermedia 
Fusobacterium nucleatum 
Staph. aureus 
Peptostreptococcus anerobius 
Porphyromonas gingivalis 
Bac 1 
Bac 2 
Bac 3 
Bac 4 
Bac 5 
Bac 6 
Bac 7 
Bac 8 
Bac 9 
Bac 10 
Bac 11 
Bac 12 
Isobutyric and isovaleric acid 
NIA 
NIA 
Acetic and propionic acid and 
isoamyl alcohol 
Isovaleric acid 
Acetic and propionic acid 
Methyl ethyl ketone, methylbutanal, 
2-butanol, pentanone, dimethyl sulfide, 
isobutanol, isopentylacetate, 2-heptanone 
isopentanol, 2-nonanone, 2-undecanone 
Acetic acid, propionic acid 
NIA 
Isovaleric acid 
Acetic, propionic and butyric acid 
Acetic, 2-butanone, 2-butanol, pentanone, 
methyl butanol, toluene, 2-heptanone, 
isopentanol, 2-nonanone, 2-undecanone, 
acetone, 2-nondecagon 
Acetic, isobutyric, butyric, isovaleric and 
isocaproic acid 
Isovaleric acid 
*This is a fungus 
Example 2 
30 TABLE 4-continued 
This Example illustrates that the apparatus and methods 
comprising the sensor arrays of the present invention are 18 SENSOR ARRAYS 
suitable for process control of anesthetic gases. Sensor Polymer and carbon black Carbon black 
As disclosed herein, a method for monitoring anesthetic 35 
gases in order to establish reliable monitoring of a patient’s 
condition while under anesthetics is possible. 
Conducting-polymer composite sensors change resistance 
when exposed to an analyte in the vapor phase, and the 
pattern of such resistance changes across an array allows 40 
identification of a concentration of an analyte. The pattern 
height allows identification of the concentration of an ana- 
lyte. The experiments show that these arrays are suitable for 
process control over the concentration of anesthetic gases at 
Using a 18-sensor array a suitable concentration of hal- 
othane was delivered. The flow rate of the carbon dioxide 
carrier gas was 10 mnL/min. The anesthetic gas flow rate 
was 0.2 mL/min, thus the ratio of carrier gas flow over the 
summation of the carrier gas flow and the anesthetic gas flow 
was 2%. FIG. 7 illustrates the response of 2% halothane on 
the sensor array. FIG. 8 illustrates the linear response for 
sensor 10 with halothane concentration. 
levels that are clinically of interest. 4s  
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TABLE 4 
18 SENSOR ARRAYS 
Sensor Polymer and carbon black Carbon black 
1. Poly(4-vinyl phenol) [24979-70-21 40 mg Carbon 6o 
M W  1500-7000 Polysciences Cat #06527 
0.160 g in 20 ml THF 
black 
(soluble in 
THF) 
2. Poly(Styrene-co-alkyllalcohol) 46 mg carbon 
Polysciences Cat #03773 black 
5.7% hydroxyl, MW 1500 (soluble in 65 
0.156 g in 20 ml THF THF) 
3. 
4. 
5. 
6. 
7. 
8. 
9. 
10. 
11. 
12. 
Poly (a-methylstyrene) [25014-31-71 
Aldrich 
0.164 g in 20 ml THF 
Poly(viny1 chloride - vinylacetate) [9003-22-91 
10% vinyl acetate 
Polysciences Cat #07058 
0.164 g in 20 ml THF 
Poly(viny1 pyrrolidone) [9003-39-81 
Aldrich 
Average Mw 10,000 
(both in TFSH @ 6 mglml) 
0.160 g in 20 ml THF 
Poly(viny1 acetate) [9003-20-71 
Polysciences 
MW:500,000 
0.163 g in 20 ml 
Poly(methy1 vinyl ether - maleic 
anhydride) [9011-16-91 
Polysciences Cat #0303 
0.162 g in TF 
Poly(bispheno1 A carbonate) [24936-68-31 
MW 32,000-36,000 
Polysciences Cat #00962 
0.169 g in 20 ml THF 
Poly(styrene) [9003-53-61 
MW 125,000-250,000 beads 
Polysciences Cat #00574 
0.160 g in THF 
Poly(styrene - maleic anhydride) [9011-13-61 
50% of each Mw 1600 
Polysciences Cat #0316 
0.160 g in 20 ml THF 
Poly(viny1 butyral) [63148-65-21 
Mw 100,000-150,000 
Polysciences Cat #06100 
0.160 g in 20 ml THF 
Poly(su1fone) [25135-51-31 
0.166 g in 20 ml THF 
41 mg carbon 
black 
39 mg carbon 
black 
41 mg carbon 
black 
42 mg carbon 
black 
39 mg carbon 
black 
39 mg carbon 
black 
41 mg carbon 
black 
40 mg carbon 
black 
41 mg carbon 
black 
40 mg carbon 
black 
US 6,319,724 B3 
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TABLE 4-continued 
18 SENSOR ARRAYS 
Sensor Polvmer and carbon black Carbon black 
13. 
14. 
1s. 
16. 
17. 
18. 
Mw 30,000 
Polysciences Cat #07074 
Poly(methy1 methacrylate) [9101-14-71 
Aldrich black 
Average Mw-120,000 
Contains 4 . 0 %  toulene 
0.162 g in 20 ml THF 
Poly(viny1idene chloride - acrylonetrile) 19010- 40 mg carbon 
41 mg carbon 
76-81 
0.161 g in THF 
Polysciences cat. #09747 
Poly(capro1actone) [24980-41-41 
Polysciences cat. #07039 
Biodegradable polymer 
0.159 g in 20 ml benzene 
Poly(ethy1ene - vinyl acetate) [24937-78-81 
0.168 g in 20 ml benzene 
82% ethylene 
Polysciences cat. #02309 
Poly(ethy1eneoxide) [25322-68-3] 
Aldrich 
Arc Mw 100000 
0.162 g in benzene 
*Sonicated each suspension for 5 min. 
Poly(9-vinyl carbazole) 
Aldrich [25067-59-3] 
18,260-5 
Ave. Mw CQ 1,100,000 
0.162 g polymer 
(8020)  
black- 
42 mg carbon 
black 
39 mg carbon 
black 
42 mg carbon 
black 
-40 mg carbon 
black 
10 
1s 
20 
2s 
30 
It is understood that the examples and embodiments 
described herein are for illustrative purposes only and that 
various modifications or changes on light thereof will be 
suggested to persons skilled in the art and are to be included 35 
within the spirit and purview of this application and scope of 
the appended claims. All publications, patents, and patent 
applications cited herein are hereby incorporated by refer- 
ence for all purposes in their entirety. 
What is claimed is: 40 
1. A method for detecting pneumonia, said method com- 
contacting an array of sensors with mammalian breath 
suspected of containing a marker gas indicative of 
detecting said marker gases to determine the presence of 
prising: 
pneumonia; and 4s  
pneumonia. 
20 
2. A method in accordance with claim 1, wherein said 
array of sensors comprises a member selected from the 
group consisting of a surface acoustic wave sensor, a quartz 
microbalance sensor; a conductive composite; a chemiresis- 
tor; a metal oxide gas sensor and a conducting polymer 
sensor, a dye-impregnated polymer film on fiber optic 
detector, a polymer-coated micromirror, an electrochemical 
gas detector, a chemically sensitive field-effect transistor, a 
carbon black-polymer composite, a micro-electro- 
mechanical system device and a micro-opto-electro- 
mechanical system device. 
3. A method in accordance with claim 1, wherein said 
marker gas is a member selected from the group consisting 
of alkanes, alkenes, alkynes, dienes, alicyclic hydrocarbons, 
arenes, alcohols, ethers, ketones, aldehydes, carbonyls, 
carbanions, polynuclear aromatics, biomolecules, sugars, 
isoprenes isoprenoids, VOC, VOA, indoles, skatoles, 
diarmines, pyridines, picolines, an off-gas of a microorgan- 
ism and fatty acids. 
4. A method in accordance with claim 1, further compris- 
ing generating a response from said sensors and inputting 
said response to a neural net trained against known marker 
gases. 
5. A method in accordance with claim 1, further compris- 
ing concentrating said mammalian breath prior to contacting 
said array of sensors. 
6. A method in accordance with claim 5, wherein said 
mammalian breath is concentrated in a breath collector 
concentrator. 
7. A method in accordance with claim 6, wherein said 
breath collector concentrator is adapted to receive breath 
from the nose, nasal passages and mouth. 
8. A method in accordance with claim 6, wherein said 
breath collector concentrator is adapted to provide breath 
from the nostril to avoid cross-contamination from the 
mouth. 
9. A method in accordance with claim 1, wherein said 
microorganism is a member selected from the group con- 
sisting of stvep. pneumoniae, mycoplasma, chlamydia 
pneumoniae, and H. flu. 
10. A method in accordance with claim 1, wherein said 
mammalian breath further comprises additional microorgan- 
ism marker gases. 
* * * * *  
